CSV export

Details about the neuroanatomical projections from SUBv to NLOT

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88578 Subiculum ventral partNucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Only a few BDA-labeled fibers were scattered in the anterior amygdaloid area and nucleus of the lateral olfactory tract at a rostralmost level. Collator note: projection not shown
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88681 Subiculum ventral partNucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88744 Subiculum ventral partNucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88778 Subiculum ventral partNucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88807 Subiculum ventral partNucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to MEAad

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88579 Subiculum ventral partMedial nucleus of the amygdala anterodorsal part moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the MEAad, caudally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88592 Subiculum ventral partMedial nucleus of the amygdala anterodorsal part moderatebiotinylated dextran amine (BDA)
Proceeding caudally, more labeled fibers were distributed in the Me (Fig. 3B). Collator note: at least moderate labeling of the rostral MEAad. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88665 Subiculum ventral partMedial nucleus of the amygdala anterodorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: terminals in the MEAad, continuing dorsally in CEA. See Fig. 5A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88756 Subiculum ventral partMedial nucleus of the amygdala anterodorsal part moderatebiotinylated dextran amine (BDA)
Collator note: moderate labeling of the caudal MEAad. See Fig. 10A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88789 Subiculum ventral partMedial nucleus of the amygdala anterodorsal part lightbiotinylated dextran amine (BDA)
Collator note: few labeled fibers in the caudal MEAad See Fig. 12A, Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to MEAav

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88580 Subiculum ventral partMedial nucleus of the amygdala anteroventral part very lightbiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: few labeled fibers in this regions, if any, caudally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88664 Subiculum ventral partMedial nucleus of the amygdala anteroventral part not presentbiotinylated dextran amine (BDA)
Collator note: the MEAav seems void of label, at least caudally. See Fig. 5A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88718 Subiculum ventral partMedial nucleus of the amygdala anteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88757 Subiculum ventral partMedial nucleus of the amygdala anteroventral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal MEAav and the neighboring BA. See Fig. 10A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88793 Subiculum ventral partMedial nucleus of the amygdala anteroventral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to CEAm

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88582 Subiculum ventral partCentral nucleus of amygdala medial part light/moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: weak-moderate labeling of CEAm, caudally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88596 Subiculum ventral partCentral nucleus of amygdala medial part light/moderatebiotinylated dextran amine (BDA)
The central nucleus displayed light labeling, which was almost localized in the CeM (Fig. 3B). Collator note: see Fig. 3B, Swanson Atlas Levels 27-28,
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88605 Subiculum ventral partCentral nucleus of amygdala medial part light/moderatebiotinylated dextran amine (BDA)
At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88608 Subiculum ventral partCentral nucleus of amygdala medial part light/moderatebiotinylated dextran amine (BDA)
A few labeled fibers ran along the medial edge of the central nucleus (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88667 Subiculum ventral partCentral nucleus of amygdala medial part moderate/strongbiotinylated dextran amine (BDA)
Collator note: see Fig. 5C, Swanson Atlas Levels 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88731 Subiculum ventral partCentral nucleus of amygdala medial part lightbiotinylated dextran amine (BDA)
Collator note: few labeled fibers in the medial part of the CEAm. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88769 Subiculum ventral partCentral nucleus of amygdala medial part lightbiotinylated dextran amine (BDA)
Collator note: few terminals and fibers in the CEAl and m. See Fig. 10A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88788 Subiculum ventral partCentral nucleus of amygdala medial part lightbiotinylated dextran amine (BDA)
Collator note: few labeled fibers in the rostral CEAm, and in the ventral CEAc. See Fig. 12A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to CEAl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88583 Subiculum ventral partCentral nucleus of amygdala lateral part very lightbiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: very sparse labeling of CEAl, caudally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88597 Subiculum ventral partCentral nucleus of amygdala lateral part very lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in the CEAl, dorsally. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88607 Subiculum ventral partCentral nucleus of amygdala lateral part light/moderatebiotinylated dextran amine (BDA)
A few labeled fibers ran along the medial edge of the central nucleus (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88668 Subiculum ventral partCentral nucleus of amygdala lateral part very lightbiotinylated dextran amine (BDA)
Collator note: see Fig. 5A-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88732 Subiculum ventral partCentral nucleus of amygdala lateral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region. See Fig. 8A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88770 Subiculum ventral partCentral nucleus of amygdala lateral part lightbiotinylated dextran amine (BDA)
Collator note: few terminals and fibers in the CEAl and m. See Fig. 10A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88792 Subiculum ventral partCentral nucleus of amygdala lateral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to CEAc

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88584 Subiculum ventral partCentral nucleus of amygdala capsular part light/moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: labeled terminals in the ventral sector of the CEAc, close to IA. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88593 Subiculum ventral partCentral nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
An area lateral to the Me, the intra-amygdaloid division of the bed nucleus of the stria terminalis (BSTIA), contained a moderate number of labeled fibers (Fig. 3B). Collator note: BSTIA is mapped here onto CEAc, ventral part and the lateral part of the MEApd. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88598 Subiculum ventral partCentral nucleus of amygdala capsular part lightbiotinylated dextran amine (BDA)
Collator note: sparse labeling of the dorsal CEAc in this level, dorsally and ventrally. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88604 Subiculum ventral partCentral nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88666 Subiculum ventral partCentral nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
Collator note: the capsular CEA, especially rostroventrally is labeled moderately. See Fig. 5A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88730 Subiculum ventral partCentral nucleus of amygdala capsular part light/moderatebiotinylated dextran amine (BDA)
Collator note: the label in CEAc is concentrated ventrally. See Fig. 8A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88755 Subiculum ventral partCentral nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
Collator note: moderate labeling in the caudal part of the ventral CEAc. See Fig. 10B-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88787 Subiculum ventral partCentral nucleus of amygdala capsular part lightbiotinylated dextran amine (BDA)
Collator note: few labeled fibers in the rostral CEAm, and in the ventral CEAc. See Fig. 12A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to IA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88585 Subiculum ventral partIntercalated nuclei of the amygdala moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: labeled terminals in the IA. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88594 Subiculum ventral partIntercalated nuclei of the amygdala moderate/strongbiotinylated dextran amine (BDA)
Collator note: strong-moderately dense labeling of the IA in this level. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88603 Subiculum ventral partIntercalated nuclei of the amygdala moderatebiotinylated dextran amine (BDA)
At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88662 Subiculum ventral partIntercalated nuclei of the amygdala very lightbiotinylated dextran amine (BDA)
[] the intercalated nucleus tended to be devoid of labeling (Fig. 5B). Collator note: Fig. 5A-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88729 Subiculum ventral partIntercalated nuclei of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: IA is practically devoid of label. See fig. 8A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88754 Subiculum ventral partIntercalated nuclei of the amygdala moderatebiotinylated dextran amine (BDA)
Collator note: moderate labeling in the caudalmost part of the IA. See Fig. 10B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88801 Subiculum ventral partIntercalated nuclei of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to BMAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88586 Subiculum ventral partBasomedial nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the BMAa in this level. The terminals tend to group dorsally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88595 Subiculum ventral partBasomedial nucleus of the amygdala anterior part strongbiotinylated dextran amine (BDA)
Dense labeling was seen in the BMA, mainly in the dorsomedial portion of this nucleus (Fig. 3B). Collator note: see Fig. 3B, Swanson Atlas Levels 27-28,
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88657 Subiculum ventral partBasomedial nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
the full extent of the BMA and BMP displayed moderate-to-intense labeling, although the ventral and lateral edges of both nuclei tended to contain fewer labeled axons (Figs. 5AD, 6A,B). Collator note: Fig. 5A-B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88714 Subiculum ventral partBasomedial nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
The BMA also displayed weak-to-moderate labeling. Collator note: caudally, BMAa looks moderately labeled. See Fig. 8B, Swanson Atlas Level 28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88715 Subiculum ventral partBasomedial nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
The BMA also displayed weak-to-moderate labeling. Collator note: see Fig. 8A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88786 Subiculum ventral partBasomedial nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the BMAa, rostrocaudally. See Fig. 12 A-B, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to LHA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88587 Subiculum ventral partLateral hypothalamic area light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the LHA, just above the optic tract. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to EPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88588 Subiculum ventral partEndopiriform nucleus dorsal part lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in the Epd, in the medial part. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88620 Subiculum ventral partEndopiriform nucleus dorsal part lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in the caudalmost part of the Epd. See Fig. 3C-D, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88678 Subiculum ventral partEndopiriform nucleus dorsal part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the EPd, at least caudally. See Fig. 5A-E, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88738 Subiculum ventral partEndopiriform nucleus dorsal part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal part of the EPd. See fig. 8 A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88771 Subiculum ventral partEndopiriform nucleus dorsal part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal part of the EPd. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88790 Subiculum ventral partEndopiriform nucleus dorsal part very lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in a single level of the EPd. See Fig. 12C, Swanson Atlas Level 29
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to SI

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88590 Subiculum ventral partSubstantia innominata moderatebiotinylated dextran amine (BDA)
Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the SI in this level. The terminals tend to group dorsally. See Fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to MEApd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88591 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part strongbiotinylated dextran amine (BDA)
Proceeding caudally, more labeled fibers were distributed in the Me (Fig. 3B). Collator note: strong labeling of the rostral MEApd. See Fig. 3B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88601 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part moderatebiotinylated dextran amine (BDA)
relatively small numbers of labeled fibers tended to terminate in the ventral and lateral parts of the Me (Fig. 3C). Collator note: terminal field in the lateral part of the MEApd, continuing in the MEApv. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88670 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part moderatebiotinylated dextran amine (BDA)
Collator note: See Fig. 5B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88716 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part very lightbiotinylated dextran amine (BDA)
At caudal levels, medial amygdaloid regions were almost free from labeling (Fig. 8C,D). Collator note: Fig 8C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88720 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88759 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: weak-moderate labeling of the rostral MEAad. See Fig. 10B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88762 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part very lightbiotinylated dextran amine (BDA)
Collator note: very few terminals in the lateral part of the caudal MEApd. See Fig. 10C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88794 Subiculum ventral partMedial nucleus of the amygdala posterodorsal part not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to COAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88599 Subiculum ventral partCortical nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
Scant labeling was also seen in the medial (PMCo) and lateral (PLCo) divisions of the posterior cortical nucleus (Fig. 3B). Collator note: Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88672 Subiculum ventral partCortical nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudal COAa, layer II. See Fig. 5A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88711 Subiculum ventral partCortical nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
Small numbers of Si (caudal SUBv) fibers terminated in the corticomedial nuclear group at rostral levels (Fig. 8A,B). Collator note: fibers and terminals in the COAa, layer II. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88763 Subiculum ventral partCortical nucleus of the amygdala anterior part lightbiotinylated dextran amine (BDA)
Collator note: few terminals in the COAa. See Fig. 10A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88791 Subiculum ventral partCortical nucleus of the amygdala anterior part very lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals and fibers in the COAa. See Fig. 12A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to COApl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88600 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone lightbiotinylated dextran amine (BDA)
Scant labeling was also seen in the medial (PMCo) and lateral (PLCo) divisions of the posterior cortical nucleus (Fig. 3B). Collator note: Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88621 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone very lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in the COApl, mostly caudally. See Fig. 3C-D, Swanson Atlas Levels 28-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88673 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone lightbiotinylated dextran amine (BDA)
Collator note: labeling of the rostral COApl, layer II. See Fig. 5B, Swanson Atlas Level 28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88713 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region. See Fig. 8A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88764 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone lightbiotinylated dextran amine (BDA)
Collator note: few terminals in layer 3 of the COApl. See Fig. 10B-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88766 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone light/moderatebiotinylated dextran amine (BDA)
Collator note: terminals in layer 3 of the caudal COApl. See Fig. 10D, Swanson Atlas Levels 30-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88795 Subiculum ventral partCortical nucleus of the amygdala posterior part lateral zone not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to MEApv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88602 Subiculum ventral partMedial nucleus of the amygdala posteroventral part moderatebiotinylated dextran amine (BDA)
relatively small numbers of labeled fibers tended to terminate in the ventral and lateral parts of the Me (Fig. 3C). Collator note: terminal field in the lateral part of the MEApd, continuing in the MEApv. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88671 Subiculum ventral partMedial nucleus of the amygdala posteroventral part moderatebiotinylated dextran amine (BDA)
Collator note: See Fig. 5B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88717 Subiculum ventral partMedial nucleus of the amygdala posteroventral part very lightbiotinylated dextran amine (BDA)
At caudal levels, medial amygdaloid regions were almost free from labeling (Fig. 8C,D). Collator note: Fig 8C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88719 Subiculum ventral partMedial nucleus of the amygdala posteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88721 Subiculum ventral partMedial nucleus of the amygdala posteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88760 Subiculum ventral partMedial nucleus of the amygdala posteroventral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the rostral MEApv. See Fig. 10B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88761 Subiculum ventral partMedial nucleus of the amygdala posteroventral part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the MEApv. See Fig. 10C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to BMAp

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88606 Subiculum ventral partBasomedial nucleus of the amygdala posterior part moderatebiotinylated dextran amine (BDA)
Relatively weak labeling was seen in the dorsomedial part of the posterior basomedical nucleus (BMP) (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88615 Subiculum ventral partBasomedial nucleus of the amygdala posterior part strongbiotinylated dextran amine (BDA)
A dense plexus of labeled fibers was present in the dorsomedial quadrant of the BMP (Fig. 3D). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88658 Subiculum ventral partBasomedial nucleus of the amygdala posterior part moderate/strongbiotinylated dextran amine (BDA)
the full extent of the BMA and BMP displayed moderate-to-intense labeling, although the ventral and lateral edges of both nuclei tended to contain fewer labeled axons (Figs. 5AD, 6A,B). Collator note: Fig. 5C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88722 Subiculum ventral partBasomedial nucleus of the amygdala posterior part moderate/strongbiotinylated dextran amine (BDA)
[..] the BMP contained a relatively large number of labeled fibers, which were concentrated in the lateral half in the rostral part of this nucleus (Fig. 8C) and in the medial half in its caudal part (Fig. 8D). Collator note: Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88750 Subiculum ventral partBasomedial nucleus of the amygdala posterior part very strongbiotinylated dextran amine (BDA)
An exceedingly large number of labeled fibers formed a terminal network involving the entire extent of the BMP and BLV (Figs. 10C, 11B). Collator note: Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88753 Subiculum ventral partBasomedial nucleus of the amygdala posterior part lightbiotinylated dextran amine (BDA)
Collator note: few labeled fibers and terminals in the caudal part of the BMAp. See Fig. 10D, Swanson Atlas Levels 30-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88785 Subiculum ventral partBasomedial nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the BMAp, rostrocaudally. See Fig. 12 B-D, Swanson Atlas Levels 27-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to BLAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88581 Subiculum ventral partBasolateral nucleus of the amygdala anterior part not presentbiotinylated dextran amine (BDA)
Collator note: no labeled fibers in this level. See fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88609 Subiculum ventral partBasolateral nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
Scant labeling was detected in the anterior basolateral nucleus (BLA) and lateral nucleus (La; Fig. 3C). Collator note: label found in the ventral part of the BLAa. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88611 Subiculum ventral partBasolateral nucleus of the amygdala anterior part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the rostral parts of the LA and BLAa, respectively. See Fig 3A-B, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88656 Subiculum ventral partBasolateral nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
The distribution density of labeled fibers in the basolateral nuclear group was higher in case R64. Collator note: Fig. 5C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88660 Subiculum ventral partBasolateral nucleus of the amygdala anterior part lightbiotinylated dextran amine (BDA)
Collator note: weak labeling in the rostral part of this nucleus. See fig. 5A-B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88723 Subiculum ventral partBasolateral nucleus of the amygdala anterior part strongbiotinylated dextran amine (BDA)
A concentration of labeled fibers was seen in the dorsomedial quadrant of the BLA (Fig. 8B,C). Collator note: Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88745 Subiculum ventral partBasolateral nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
[] moderate numbers of labeled fibers were distributed diffusely in the BLA and were concentrated in the middle one-third of the dorsoventral extent of the La (Figs. 10A, 11A). Collator note: Swanson Atlas Levels 26-27
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88747 Subiculum ventral partBasolateral nucleus of the amygdala anterior part very strongbiotinylated dextran amine (BDA)
Collator note: very strong labeling in the medial corner of the caudal BLAa. See Fig. 10C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88780 Subiculum ventral partBasolateral nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
[] labeled fibers formed a plexus of labeled axons in an area involving the ventromedial La and adjacent portion of the BLA. Collator note: Fig. 12B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88782 Subiculum ventral partBasolateral nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
Collator note: terminal field in BLAa, tending to agglomerate laterally in this level. See Fig. 12C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to LA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88589 Subiculum ventral partLateral nucleus of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: no labeled fibers in this level. See fig. 3A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88610 Subiculum ventral partLateral nucleus of the amygdala lightbiotinylated dextran amine (BDA)
Scant labeling was detected in the anterior basolateral nucleus (BLA) and lateral nucleus (La; Fig. 3C). Collator note: labeld in the medial part of the LA. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88612 Subiculum ventral partLateral nucleus of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: no label in the rostral parts of the LA and BLAa, respectively. See Fig 3A-B, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88617 Subiculum ventral partLateral nucleus of the amygdala very lightbiotinylated dextran amine (BDA)
Only a few labeled fibers were scattered in the ventromedial part of the La (Fig. 3D). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88669 Subiculum ventral partLateral nucleus of the amygdala moderate/strongbiotinylated dextran amine (BDA)
Collator note: distinct terminal field in the LA, caudalmost, and restricted to the ventral part. See Fig. 5C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88724 Subiculum ventral partLateral nucleus of the amygdala light/moderatebiotinylated dextran amine (BDA)
[] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: a diagonal field traverses LA in this level. Swanson Atlas Level 28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88725 Subiculum ventral partLateral nucleus of the amygdala moderatebiotinylated dextran amine (BDA)
[] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: label concentrated in the ventral half of the nucleus. Fig. 8C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88726 Subiculum ventral partLateral nucleus of the amygdala moderate/strongbiotinylated dextran amine (BDA)
[] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88746 Subiculum ventral partLateral nucleus of the amygdala moderate/strongbiotinylated dextran amine (BDA)
[] moderate numbers of labeled fibers were distributed diffusely in the BLA and were concentrated in the middle one-third of the dorsoventral extent of the La (Figs. 10A, 11A). Collator note: the terminal field in the ventral LA is present almost in the rostro-caudal extent. See fig. 10A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88752 Subiculum ventral partLateral nucleus of the amygdala lightbiotinylated dextran amine (BDA)
[.] limited numbers of labeled fibers were scattered in the ventrolateral part of the La (Fig. 10D). Collator note: Swanson Atlas Levels 30-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88779 Subiculum ventral partLateral nucleus of the amygdala moderate/strongbiotinylated dextran amine (BDA)
[] labeled fibers formed a plexus of labeled axons in an area involving the ventromedial La and adjacent portion of the BLA. Collator note: Fig. 12B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88781 Subiculum ventral partLateral nucleus of the amygdala moderatebiotinylated dextran amine (BDA)
Collator note: terminal field in the ventrolateral corner of the mid-rostrocaudal LA. See Fig. 12C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to PA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88613 Subiculum ventral partPosterior nucleus of the amygdala moderatebiotinylated dextran amine (BDA)
[] the amygdalohippocampal transition area (AHi) displayed light and diffuse labeling (Fig. 3D). Within the AHi, more caudal parts contained more labeled fibers and terminals. Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88674 Subiculum ventral partPosterior nucleus of the amygdala light/moderatebiotinylated dextran amine (BDA)
Collator note: terminals in the PA, and the neighboring regions. See Fig. 5E, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88734 Subiculum ventral partPosterior nucleus of the amygdala lightbiotinylated dextran amine (BDA)
Collator note: possibly several labeled terminals and fibers in the lateral part of the PA. See Fig. 8D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88767 Subiculum ventral partPosterior nucleus of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88798 Subiculum ventral partPosterior nucleus of the amygdala not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to COApm

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88614 Subiculum ventral partCortical nucleus of the amygdala posterior part medial zone light/moderatebiotinylated dextran amine (BDA)
Labeled axons were relatively sparsely distributed in the dorsal two-thirds of the PMCo (Fig. 3D). Collator note: PMCo is mapped here onto COApm, caudally. Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88675 Subiculum ventral partCortical nucleus of the amygdala posterior part medial zone light/moderatebiotinylated dextran amine (BDA)
Collator note: dorsal labeling of the COAPm, layers II-III. See Fig. 5D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88733 Subiculum ventral partCortical nucleus of the amygdala posterior part medial zone light/moderatebiotinylated dextran amine (BDA)
Collator note: COApm is labeled caudally, in layer 3. See Fig. 8D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88768 Subiculum ventral partCortical nucleus of the amygdala posterior part medial zone not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88796 Subiculum ventral partCortical nucleus of the amygdala posterior part medial zone not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to BLAp

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88616 Subiculum ventral partBasolateral nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
The medial half of the posterior basolateral nucleus (BLP) showed weak labeling (Fig. 3D). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88659 Subiculum ventral partBasolateral nucleus of the amygdala posterior part moderate/strongbiotinylated dextran amine (BDA)
The distribution density of labeled fibers in the basolateral nuclear group was higher in case R64. Collator note: strong labeling of the BLAp, caudalmost. See Fig. 5D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88727 Subiculum ventral partBasolateral nucleus of the amygdala posterior part lightbiotinylated dextran amine (BDA)
Collator note: few labeled terminals in this level. Fig 8C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88728 Subiculum ventral partBasolateral nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeld of the BLAp, caudally. See Fig. 8D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88749 Subiculum ventral partBasolateral nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
[] the BLP was weakly labeled (Fig. 10B). Collator note: Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88751 Subiculum ventral partBasolateral nucleus of the amygdala posterior part moderate/strongbiotinylated dextran amine (BDA)
11B). Caudal regions of the BLP showed moderate-to-intense labeling with apparent lateral predominance (Fig. 10D). Collator note: Swanson Atlas Levels 30-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88783 Subiculum ventral partBasolateral nucleus of the amygdala posterior part moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudal BLAp. See Fig. 12C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to CP

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88618 Subiculum ventral partCaudoputamen light/moderatebiotinylated dextran amine (BDA)
Collator note: label in the ventrocaudal corner of the CP. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to PAA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88623 Subiculum ventral partPiriform-amygdaloid area not presentbiotinylated dextran amine (BDA)
Collator note: no label found in the cortical amygdalar nuclei.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88676 Subiculum ventral partPiriform-amygdaloid area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region. See Fig. 5D-E, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88736 Subiculum ventral partPiriform-amygdaloid area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region. See Fig. 8D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88765 Subiculum ventral partPiriform-amygdaloid area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88797 Subiculum ventral partPiriform-amygdaloid area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to EPv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88619 Subiculum ventral partEndopiriform nucleus ventral part not presentbiotinylated dextran amine (BDA)
Collator note: no labeling of the Epv. See Fig. 3C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88661 Subiculum ventral partEndopiriform nucleus ventral part lightbiotinylated dextran amine (BDA)
The BLV showed very light labeling (Fig. 5B,C) that did not receive efferents from the rostral Sv (Fig. 3B,C). Collator note: BLV is mapped here as Epv. See Fig. 5B-C, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88737 Subiculum ventral partEndopiriform nucleus ventral part lightbiotinylated dextran amine (BDA)
Collator note: Epv (BLV) has several labeled fibers and terminals. See Fig. 8B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88748 Subiculum ventral partEndopiriform nucleus ventral part very strongbiotinylated dextran amine (BDA)
Many labeled fibers also accumulated in the medial edge of the La as well as in the dorsomedial quadrant of the BLV (Fig. 10B). Collator note: Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88784 Subiculum ventral partEndopiriform nucleus ventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the EPv, rostrocaudally. See Fig. 10B-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to TR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88624 Subiculum ventral partPostpiriform transition area not presentbiotinylated dextran amine (BDA)
Collator note: no label found in the cortical amygdalar nuclei.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88677 Subiculum ventral partPostpiriform transition area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region. See Fig. 5D-E, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88735 Subiculum ventral partPostpiriform transition area not presentbiotinylated dextran amine (BDA)
Collator note: no label in TR, at least rostrally. See Fig. 8D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88799 Subiculum ventral partPostpiriform transition area not presentbiotinylated dextran amine (BDA)
Collator note: no label in this region.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to PIR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88622 Subiculum ventral partPiriform area not presentbiotinylated dextran amine (BDA)
Collator note: PIR does not include any labeled terminals at least caudally. See Fig. 3A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88679 Subiculum ventral partPiriform area not presentbiotinylated dextran amine (BDA)
Collator note: no label in the PIR, at least caudally. See Fig. 5A-E, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88739 Subiculum ventral partPiriform area not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal part of the PIR. See fig. 8 A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88772 Subiculum ventral partPiriform area not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal part of the PIR. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88800 Subiculum ventral partPiriform area not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal part of the PIR. See fig. 12 A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to ENTl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88740 Subiculum ventral partEntorhinal area, lateral part moderatebiotinylated dextran amine (BDA)
Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88775 Subiculum ventral partEntorhinal area, lateral part moderate/strongbiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88804 Subiculum ventral partEntorhinal area, lateral part moderatebiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans

Details about the neuroanatomical projections from SUBv to PERI

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88741 Subiculum ventral partPerirhinal area moderatebiotinylated dextran amine (BDA)
Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88774 Subiculum ventral partPerirhinal area moderate/strongbiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88803 Subiculum ventral partPerirhinal area moderatebiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans

Details about the neuroanatomical projections from SUBv to AAA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88680 Subiculum ventral partAnterior amygdaloid area moderatebiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88743 Subiculum ventral partAnterior amygdaloid area lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88777 Subiculum ventral partAnterior amygdaloid area moderatebiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88806 Subiculum ventral partAnterior amygdaloid area lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88808 Subiculum ventral partAnterior amygdaloid area lightbiotinylated dextran amine (BDA)
Only a few BDA-labeled fibers were scattered in the anterior amygdaloid area and nucleus of the lateral olfactory tract at a rostralmost level. Collator note: projection not shown
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R64, the BDA injection site was on the lateral portion of the caudal Sv (Fig. 1C). Collator note: injection completely included in the SUBv, mid-rostrocaudal. The injection site is annotated here onto Swanson Atlas Level 39 (-6.0 mm from bregma).

Details about the neuroanatomical projections from SUBv to BA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88625 Subiculum ventral partBed nucleus of the accessory olfactory part not presentbiotinylated dextran amine (BDA)
Collator note: no label found in the cortical amygdalar nuclei.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88663 Subiculum ventral partBed nucleus of the accessory olfactory part not presentbiotinylated dextran amine (BDA)
Collator note: the BA seems void of label. See Fig. 5A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88712 Subiculum ventral partBed nucleus of the accessory olfactory part not presentbiotinylated dextran amine (BDA)
Collator note: no fibers in the BA. See Fig. 8A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88758 Subiculum ventral partBed nucleus of the accessory olfactory part not presentbiotinylated dextran amine (BDA)
Collator note: no label in the caudal MEAav and the neighboring BA. See Fig. 10A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A.

Details about the neuroanatomical projections from SUBv to ECT

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88742 Subiculum ventral partEctorhinal area moderatebiotinylated dextran amine (BDA)
Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88776 Subiculum ventral partEctorhinal area moderate/strongbiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88805 Subiculum ventral partEctorhinal area moderatebiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans

Details about the neuroanatomical projections from SUBv to AIp

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88773 Subiculum ventral partAgranular insular area posterior part moderate/strongbiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88802 Subiculum ventral partAgranular insular area posterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R70, BDA was injected into the mid-dorsoventral portion of the Si (Figs. 1E, 9). Collator note: injection in the caudal-intermediate part of the SUBv. The injection site is completely included in the region. The injection site is annotated here on

Details about the neuroanatomical projections from CA1 to NLOT

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88655 Field CA1Nucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88710 Field CA1Nucleus of the lateral olfactory tract lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to MEAad

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88633 Field CA1Medial nucleus of the amygdala anterodorsal part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88694 Field CA1Medial nucleus of the amygdala anterodorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: Fig 7A, Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to MEAav

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88634 Field CA1Medial nucleus of the amygdala anteroventral part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88695 Field CA1Medial nucleus of the amygdala anteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: Fig 7A, Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to CEAm

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88641 Field CA1Central nucleus of amygdala medial part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88697 Field CA1Central nucleus of amygdala medial part moderatebiotinylated dextran amine (BDA)
Collator note: Fig 7A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to CEAl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88639 Field CA1Central nucleus of amygdala lateral part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88698 Field CA1Central nucleus of amygdala lateral part very lightbiotinylated dextran amine (BDA)
Collator note: few fibers in the CEAl, rostrocaudally. See Fig. 7A-C, Swanson Atlas Levels 25-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to CEAc

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88640 Field CA1Central nucleus of amygdala capsular part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88682 Field CA1Central nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
At a rostral level, moderate numbers of labeled fibers were distributed in a narrow vertical area between the central nucleus and BLA (Fig. 7A). Collator note: the band is annotated here in the rostral CEAc. See Fig. 7A, Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88696 Field CA1Central nucleus of amygdala capsular part moderatebiotinylated dextran amine (BDA)
Collator note: Fig 7A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to IA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88626 Field CA1Intercalated nuclei of the amygdala strongbiotinylated dextran amine (BDA)
Characteristically, CA1 fibers labeled with BDA accumulated densely in the intercalated nucleus (Fig. 4AC). Collator note: dense labeling of the IA, especially caudally. Swanson Atlas Levels 26-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88683 Field CA1Intercalated nuclei of the amygdala moderate/strongbiotinylated dextran amine (BDA)
The intercalated nucleus displayed moderate-tointense labeling especially at rostral levels (Fig. 7A). Collator note: Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to BMAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88648 Field CA1Basomedial nucleus of the amygdala anterior part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88686 Field CA1Basomedial nucleus of the amygdala anterior part moderatebiotinylated dextran amine (BDA)
Collator note: BMAa is at least moderately labeled rostrocaudally. See fig. 7A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to EPd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88643 Field CA1Endopiriform nucleus dorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudalmost part of the Epd. See Fig. 4D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88704 Field CA1Endopiriform nucleus dorsal part lightbiotinylated dextran amine (BDA)
Collator note: few fibers and terminals in the Epd, caudally. See Fig. 7A-D, Swanson Atlas Levels 25-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to MEApd

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88632 Field CA1Medial nucleus of the amygdala posterodorsal part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88702 Field CA1Medial nucleus of the amygdala posterodorsal part light/moderatebiotinylated dextran amine (BDA)
Collator note: uniform terminal field in the MEAp, especially in mode rostral part. See Fig. 7B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to COAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88649 Field CA1Cortical nucleus of the amygdala anterior part not presentbiotinylated dextran amine (BDA)
Collator note: basically no labeled fibers in the COAa. See Fig. 4A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88700 Field CA1Cortical nucleus of the amygdala anterior part light/moderatebiotinylated dextran amine (BDA)
Collator note: label of layer II. See Fig. 7A-B, Swanson Atlas Levels 25-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to COApl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88635 Field CA1Cortical nucleus of the amygdala posterior part lateral zone lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88688 Field CA1Cortical nucleus of the amygdala posterior part lateral zone moderate/strongbiotinylated dextran amine (BDA)
At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to MEApv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88631 Field CA1Medial nucleus of the amygdala posteroventral part lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4B-C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88701 Field CA1Medial nucleus of the amygdala posteroventral part light/moderatebiotinylated dextran amine (BDA)
Collator note: uniform terminal field in the MEAp, especially in mode rostral part. See Fig. 7B, Swanson Atlas Levels 27-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to BMAp

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88629 Field CA1Basomedial nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
Relatively small numbers of labeled fibers were seen in the BMP (Fig. 4C,D). Collator note: Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88687 Field CA1Basomedial nucleus of the amygdala posterior part strongbiotinylated dextran amine (BDA)
Collator note: strong labeling of the BMAp, rostrocaudally. See Fig. 7C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to BLAa

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88627 Field CA1Basolateral nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
The BLA displayed moderate labeling with caudal predominance (Fig. 4B,C). Collator note: increase of labeling of the BLAa from almost no label (Fig. 4A, Swanson Atlas Levels 26-27) to weak-moderate (Fig. 4B, Swanson Atlas Level 28), to quite strong (Fig. 4C, Swanson Atlas Level 29).
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88684 Field CA1Basolateral nucleus of the amygdala anterior part moderate/strongbiotinylated dextran amine (BDA)
Within the BLA and BLP, the distribution area of labeled fibers extended more laterally in case R65 (Fig. 7C,D) than did that in case R64 (Fig. 5C,D). Collator note: Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to LA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88638 Field CA1Lateral nucleus of the amygdala light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudoventral part of the LA. See Fig. 4D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88693 Field CA1Lateral nucleus of the amygdala moderatebiotinylated dextran amine (BDA)
Collator note: fibers and terminals in the caudal LA, tending to group ventrally. See Fig. 7C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to PA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88646 Field CA1Posterior nucleus of the amygdala very lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88692 Field CA1Posterior nucleus of the amygdala light/moderatebiotinylated dextran amine (BDA)
Collator note: clear label in PA. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to COApm

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88630 Field CA1Cortical nucleus of the amygdala posterior part medial zone strongbiotinylated dextran amine (BDA)
There was an accumulation of labeled fibers in a narrow area between the Ahi and PLCo and an adjacent portion of the PLCo. Collator note: region mapped here onto layer 3 of caudal COApm. See Fig. 4D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88636 Field CA1Cortical nucleus of the amygdala posterior part medial zone lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88689 Field CA1Cortical nucleus of the amygdala posterior part medial zone moderate/strongbiotinylated dextran amine (BDA)
At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to BLAp

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88628 Field CA1Basolateral nucleus of the amygdala posterior part light/moderatebiotinylated dextran amine (BDA)
The BLA displayed moderate labeling with caudal predominance (Fig. 4B,C). Collator note: Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88685 Field CA1Basolateral nucleus of the amygdala posterior part strongbiotinylated dextran amine (BDA)
Within the BLA and BLP, the distribution area of labeled fibers extended more laterally in case R65 (Fig. 7C,D) than did that in case R64 (Fig. 5C,D). Collator note: Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to CP

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88647 Field CA1Caudoputamen moderatebiotinylated dextran amine (BDA)
Collator note: label in the ventrocaudal corner of the CP. See Fig. 4C, Swanson Atlas Levels 28-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88705 Field CA1Caudoputamen light/moderatebiotinylated dextran amine (BDA)
Collator note: label in the ventral corner of the caudal CP. See Fig 7C, Swanson Atlas Level 29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to PAA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88637 Field CA1Piriform-amygdaloid area lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88690 Field CA1Piriform-amygdaloid area light/moderatebiotinylated dextran amine (BDA)
At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to EPv

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88644 Field CA1Endopiriform nucleus ventral part lightbiotinylated dextran amine (BDA)
Collator note: labeling of the EPv, mainly dorsally. See Fig. 4B-D, Swanson Atlas Levels 26-32
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88703 Field CA1Endopiriform nucleus ventral part lightbiotinylated dextran amine (BDA)
Collator note: few fibers and terminals in the EPv (BLV of authors), rostrocaudally. See Fig. 7B-C, Swanson Atlas Levels 27-29.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to TR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88645 Field CA1Postpiriform transition area very lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4AD). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88691 Field CA1Postpiriform transition area lightbiotinylated dextran amine (BDA)
Collator note: at least several labeled terminals in the rostralmost TR. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to PIR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88650 Field CA1Piriform area moderatebiotinylated dextran amine (BDA)
Collator note: increase of the labeling of the PIR, caudally. The highest labeling in shown in Fig 4D, Swanson Atlas Levels 31-32, layer II.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88706 Field CA1Piriform area light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the caudalmost part of the PIR, layer II. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to ENTl

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88651 Field CA1Entorhinal area, lateral part light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the deep layers III-VI of the rostral ENTl and of the PERI. See Fig. 4C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88707 Field CA1Entorhinal area, lateral part light/moderatebiotinylated dextran amine (BDA)
Collator note: label of the rostral levels of the ENTl and PERI, layers III-VI. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to PERI

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88652 Field CA1Perirhinal area light/moderatebiotinylated dextran amine (BDA)
Collator note: labeling of the deep layers III-VI of the rostral ENTl and of the PERI. See Fig. 4C-D, Swanson Atlas Levels 29-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88708 Field CA1Perirhinal area light/moderatebiotinylated dextran amine (BDA)
Collator note: label of the rostral levels of the ENTl and PERI, layers III-VI. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to CLA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88653 Field CA1Claustrum light/moderatebiotinylated dextran amine (BDA)
Collator note: group of terminals in the caudal part of the CLA, just above the Epd. See Fig 4A-B, Swanson Atlas Levels 26-28.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to AAA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88654 Field CA1Anterior amygdaloid area lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88709 Field CA1Anterior amygdaloid area lightbiotinylated dextran amine (BDA)
Collator note: data shown in Table 1, page 365.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Details about the neuroanatomical projections from CA1 to BA

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88642 Field CA1Bed nucleus of the accessory olfactory part not presentbiotinylated dextran amine (BDA)
Collator note: no labeling in BA, at least caudally. See Fig. 4A, Swanson Atlas Levels 26-27.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88699 Field CA1Bed nucleus of the accessory olfactory part very lightbiotinylated dextran amine (BDA)
Collator note: 1-2 labeled fibers in the BA. See Fig.7A, Swanson Atlas Levels 25-26.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f